Editors
Kelly K. Hunt, MD, FACS, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Sections and Section Editors
Breast Cancer Genetics
Olutayo Sogunro, DO, MS, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Translational Research
Cynthia X. Ma, MD, PHD, Washington University School of Medicine, St. Louis, Missouri, USA
Breast Cancer Disparities
Lisa A. Newman, MD, MPH, FACS, Weill Cornell Medicine, New York, NY, USA
Survivorship: Important Considerations After Breast Cancer Treatment
Andrea Barrio, MD, FACS, Memorial Sloan Kettering Cancer Center, West Harrison, NY, USA
Sarah McLaughlin, MD, Mayo Clinic in Florida, Jacksonville, FL, USA
Radiation Oncology
Bruce Haffty, MD, MS, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
Fertility Issues and Breast Cancer
Jacqueline Jeruss, MD, PhD, University of Michigan Medical School, Ann Arbor, Michigan, USA
Local-Regional Evaluation and Therapy
Amanda Kong, MD, MS, FACS, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Kandice Ludwig, MD, Schwarz Cancer Center, IU Health North Hospital, Carmel, IN, USA
Global Oncology
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C), Yale Institute for Global Health, New Haven, CT
Clinical Trials
Julie E. Lang, MD, Cleveland Clinic Main Campus, Cleveland, OH, USA
High Risk Lesions and Breast Cancer Prevention
Sarah Tevis, MD, University of Colorado Medicine, Denver, CO, USA
Breast Cancer Screening & Imaging
Mahesh Shetty, MD, Baylor College of Medicine, Houston, TX, USA
Editorial Board
Kathy S. Albain, MD, Loyola University Chicago, Chicago, IL, USA
Baffour Awuah, MD, Komfo Anokye Teaching Hospital, Kumasi, Ghana
Carlos Barrios, MD, Oncology Hospital Sao Lucas, Pontifícia Universidade do Rio Grande do Sul, Porto Alegre, Brazil
Jonas Bergh, MD, Karolinska Institute/Karolinska University Hospital, Stockholm, Sweden
Judy C. Boughey, MD, Mayo Clinic, Rochester, MN, USA
Frances Boyle, MD, The Mater Hospital, North Sydney, New South Wales, Australia
Fatima Cardoso, MD, Champalimaud Cancer Center, Lisbon, Portugal
Eduardo L. Cazap, MD, PhD, FASCO, Latin American and Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Serena Di Cosimo, MD, Fondazione IRCCS Istituto, Milan, Italy
Angelo Di Leo, MD, PhD, Department of Oncology Hospital of Prato, Istituto Toscani Tumori, Prato, Italy
Michael Gnant, MD, Medical University of Vienna, Vienna, Austria
William J. Gradishar, MD, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
Julie R. Gralow, MD, University of Washington School of Medicine, Seattle, WA, USA
Sudeep Gupta, MD, Tata Memorial Centre Hospital, Mumbai, India
Nadia Harbeck, MD, PhD, University of Munich, Munich, Germany
Gabriel N. Hortobagyi, MD, FACP, University of Texas MD Anderson Cancer Center Houston, TX, USA
Sung-Bae Kim, MD, PhD, College of Medicine, University of Ulsan, Seoul, Korea
Louis Mauriac, MD, Bergonié Institute, Regional Cancer Center, Bordeaux, France
David Miles, MD, Mount Vernon Cancer Centre, London, United Kingdom
Bjorn Naume, MD, PhD, Oslo University Hospital, Oslo, Norway
Lisa A. Newman, MD, MPH, FACS, University of Michigan Medical School, Ann Arbor, Michigan, USA
Omar Sherif Omar, MD, Cairo University, Cairo, Egypt
Martine Piccart, MD, PhD, Jules Bordet Institute, Brussels, Belgium
Kathy I. Pritchard, MD, FRCP, Sunnybrook Odette Cancer Centre, Toronto, Canada
George W. Sledge Jr., MD, Indiana University School of Medicine, Indianapolis, IN, USA
Daniel A. Vorobiof, MD, (Sandton Oncology Centre, Johannesburg, South Africa
Toru Watanabe, MD, Hamamatsu Oncology Center, Hamamatsu, Japan